013 — Post-Partum Depression, Endometrial Cancer, mCRC, and Ebolavirus
Here is information on the latest US FDA approvals, the week of July 31 – August 4, 2023. Zurzuvae, the First-Ever Pill for Post-Partum DepressionThe FDA has granted approval of…
012 — RiVive, Balfaxar, Xdemvy
Here is information on the latest US FDA approvals, the week of July 24 – July 28, 2023. RiVive OTC Approval for Opioid OverdoseThe FDA has approved RiVive, a 3…
003 — Inpefa, Paxlovid, TheLinkBCI, Xacduro, Brixadi, Opvee
Here is information on the latest US FDA approvals, the week of May 22 – May 26, 2023. Please subscribe, rate and review. Thank you!Inpefa (sotagliflozin) for heart failureThe FDA…